ReviewPharmaceuticals (Basel, Switzerland)2021

Neuropsychiatric Disorders and COVID-19: What We Know So Far.

Fernanda Majolo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.